Our results suggest that AGEs affected AQP3 protein expression in a dose-dependent manner, with different effects basally versus under conditions of enhanced protein acetylation as has been observed in diabetes [30,31,32,33]. This evidence concerns the gene AQP3 and diabetes mellitus.